Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 USD | -33.33% | -46.67% | -87.04% |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Mar. 12 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
Financials (USD)
Sales 2021 | 52.9M | Sales 2022 | 62.84M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2021 | -428M | Net income 2022 | -573M | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M | Net Debt 2022 | 84.53M | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | 949 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
1 day | -14.29% | ||
1 week | -17.24% | ||
Current month | +200.00% | ||
1 month | +118.18% | ||
3 months | -71.76% | ||
6 months | -77.70% | ||
Current year | -80.57% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 88-12-31 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 14-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 12-03-31 |
David Lemus
BRD | Director/Board Member | 61 | 17-09-30 |
Jaisim Shah
BRD | Director/Board Member | 63 | 13-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.016 | -33.33% | 164 132 |
24-04-18 | 0.024 | -14.29% | 56,700 |
24-04-17 | 0.028 | +1.82% | 42,473 |
24-04-16 | 0.0275 | -16.67% | 53,447 |
24-04-15 | 0.033 | +10.00% | 1,981,522 |
Delayed Quote OTC Markets, April 18, 2024 at 03:52 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-80.57% | 13.05M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.27% | 21.66B | |
-18.35% | 20.77B | |
-8.28% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- SRNE Stock